Bill Text: NJ S3298 | 2018-2019 | Regular Session | Introduced
Bill Title: Prohibits pharmaceutical manufacturer from owning or operating drug rehabilitation facility licensed in State.
Spectrum: Partisan Bill (Democrat 1-0)
Status: (Introduced - Dead) 2019-01-15 - Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee [S3298 Detail]
Download: New_Jersey-2018-S3298-Introduced.html
Sponsored by:
Senator LINDA R. GREENSTEIN
District 14 (Mercer and Middlesex)
SYNOPSIS
Prohibits pharmaceutical manufacturer from owning or operating drug rehabilitation facility licensed in State.
CURRENT VERSION OF TEXT
As introduced.
An Act concerning drug rehabilitation facilities and supplementing Title 26 of the Revised Statutes.
Be It Enacted by the Senate and General Assembly of the State of New Jersey:
1. The Division of Mental Health and Addiction Services in the Department of Human Services shall not grant or renew the license of a facility that provides treatment or other services to individuals with a substance use disorder if the facility is owned or operated, wholly, partially, directly, indirectly, or in any manner, by a manufacturer of pharmaceutical products.
2. Pursuant to the "Administrative Procedure Act," P.L.1968, c.410 (C.52:14B-1 et seq.), the Department of Human Services may adopt rules and regulations necessary to effectuate the provisions of this act.
3. This act shall take effect 180 days after the date of enactment.
STATEMENT
This bill prohibits a pharmaceutical manufacturer from owning or operating a drug rehabilitation facility licensed in this State. Under the bill, the Division of Mental Health and Addiction Services in the Department of Human Services is not to grant or renew the license of a facility that provides treatment or other services to individuals with a substance use disorder if the facility is owned or operated, wholly, partially, directly, indirectly, or in any manner, by a manufacturer of pharmaceutical products.
